Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

Leb, G; Warnkross, H; Obermayer-Pietsch, B.
Thyroid hormone excess and osteoporosis.
Acta Med Austriaca. 1994; 21(2):65-67
Web of Science PubMed

Co-Autor*innen der Med Uni Graz: Obermayer-Pietsch Barbara
Altmetrics:
Dimensions Citations:
Plum Analytics:
Abstract:: Current thinking and available clinical data on the relationship between hyperthyroidism and bone disease are discussed. Data are also presented on TSH-suppressive and non-suppressive thyroid hormone therapy and its effect on bone. Although these data are clearly inconsistent, some risk factors for thyroid hormone induced osteopenia seem to be accepted: long standing, clinically manifest hyperthyroidism (a very rare disorder today because of early diagnosis and appropriate therapy), old age, menopause and total thyroidectomy. Thyroid hormone therapy (whether TSH-suppressive or not) has not been proven so far to lead to manifest osteoporosis.
Find related publications in this database (using NLM MeSH Indexing): Adult -; Aged -; Antithyroid Agents - adverse effects; Bone Diseases, Metabolic - chemically induced; Female - chemically induced; Humans - chemically induced; Hyperthyroidism - chemically induced; Male - chemically induced; Middle Aged - chemically induced; Osteoporosis - chemically induced; Risk Factors - chemically induced; Thyroid Hormones - physiology; Thyrotropin - antagonists and inhibitors
Find related publications in this database (Keywords): Hyperthyroidism; Thyroid Hormone Treatment; Replacement Therapy; Suppressive Therapy; Osteoporosis